Brightling Christopher E, Symon Fiona A, Birring Surinder S, Bradding Peter, Pavord Ian D, Wardlaw Andrew J
Division of Respiratory Medicine, Institute for Lung Health, Leicester-Warwick Medical School and University Hospitals of Leicester, Leicester, United Kingdom.
J Allergy Clin Immunol. 2002 Dec;110(6):899-905. doi: 10.1067/mai.2002.129698.
Asthma is characterized by variable airflow obstruction and airway hyperresponsiveness in association with airway inflammation under the influence of T(H)2 cytokines. Eosinophilic bronchitis has similar immunopathology to asthma but without disordered airway physiology. Whether eosinophilic bronchitis is associated with increased expression of T(H)2 cytokines is unknown.
We sought to assess the expression of T(H)2 cytokines in eosinophilic bronchitis.
Expression of activation markers and chemokine receptors from blood and bronchoalveolar lavage (BAL) fluid T cells and the T(H)2 cytokine expression from these T cells and bronchial mucosa biopsy specimens were assessed from subjects with eosinophilic bronchitis, subjects with asthma, and healthy control subjects.
The proportion of resting (stimulated) CD4 BAL fluid T cells expressing intracellular IL-4 was significantly higher in the subjects with eosinophilic bronchitis 7.2% (11.4%) and subjects with asthma 5.3% (5.5%) than in healthy control subjects 2.8% (3.9%) (P =.03). The number of IL-4(+) (P <.001) and IL-5(+) (P =.003) cells per square millimeter of bronchial submucosa was significantly higher in the disease groups than in the healthy control subjects. Expression of intracellular IFN-gamma was significantly higher in stimulated blood CD8 T cells from subjects with eosinophilic bronchitis (24%) and asthma (17%) than in the healthy control subjects (5%; P =.003). There were no between-group differences in expression of IFN-gamma in the BAL fluid T cells or in the bronchial submucosa and no differences in expression of activation markers or chemokine receptors.
These findings support the concept of asthma as a disease associated with activation of T(H)2 lymphocytes in the airway and provide evidence that these cytokines play a role in the development of airway inflammation in eosinophilic bronchitis but suggest that the release of T(H)2 cytokines is not sufficient for the elaboration of disordered airway physiology in asthma.
哮喘的特征是在T(H)2细胞因子的影响下,伴有气道炎症的可变气流阻塞和气道高反应性。嗜酸性粒细胞性支气管炎具有与哮喘相似的免疫病理学,但气道生理功能无紊乱。嗜酸性粒细胞性支气管炎是否与T(H)2细胞因子表达增加有关尚不清楚。
我们试图评估嗜酸性粒细胞性支气管炎中T(H)2细胞因子的表达。
从嗜酸性粒细胞性支气管炎患者、哮喘患者和健康对照者中评估血液和支气管肺泡灌洗(BAL)液T细胞的活化标志物和趋化因子受体表达,以及这些T细胞和支气管黏膜活检标本中的T(H)2细胞因子表达。
嗜酸性粒细胞性支气管炎患者(7.2%[11.4%])和哮喘患者(5.3%[5.5%])中表达细胞内白细胞介素-4(IL-4)的静息(刺激后)CD4 BAL液T细胞比例显著高于健康对照者(2.8%[3.9%])(P = 0.03)。疾病组每平方毫米支气管黏膜下层中IL-4(+)(P < 0.001)和IL-5(+)(P = 0.003)细胞数量显著高于健康对照者。嗜酸性粒细胞性支气管炎患者(24%)和哮喘患者(17%)刺激后血液CD8 T细胞中细胞内γ干扰素(IFN-γ)表达显著高于健康对照者(5%;P = 0.003)。BAL液T细胞或支气管黏膜下层中IFN-γ表达在组间无差异,活化标志物或趋化因子受体表达也无差异。
这些发现支持哮喘是一种与气道中T(H)2淋巴细胞活化相关疾病的概念,并提供证据表明这些细胞因子在嗜酸性粒细胞性支气管炎气道炎症发展中起作用,但提示T(H)2细胞因子的释放不足以引发哮喘中紊乱的气道生理功能。